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 Dr. Ken Warner has been Dean of the UM 
School of Public Health since 2005. He stumbled 
upon Public Health from a background in Economics, 
and his research since that career move has focused 
on preventing disease and promoting health through 
economic and policy measures with a focus on to-
bacco policy. He also worked to initiate and currently 
teaches the first and only undergraduate Public 
Health course (HMP 200: Introduction to Public 
Health).
How would you define public health?
 Public health is the set of activities a society 
undertakes to monitor and improve the health of its 
collective membership. It has three distinguishing 
features: a focus on preventing disease & injury, the 
idea that the “patient” is the entire community (not
individuals); and that the “provider” is society (and 
not individual professionals). 
How do you work and interact with other health 
professionals?
 I do this in all kinds of different ways. The 
people I work with are not all health professionals,
but rather people oriented towards health. Tobacco 
control is the area I’ve worked in most of my career 
and I was the World Bank’s delegate to the nego-
tiations that put the international tobacco control 
treaty together (known formally as the Framework 
Convention on Tobacco Control). That’s kind of at 
the 30,000 foot level. At the local level I work with 
folks at the Washtenaw County Department of
Health. I also collaborate with senators and leg-
islators in Lansing trying to pass the Smoke-Free 
Workplace Law. We work very closely with people 
in Washington, D.C. who are involved with tobacco 
control organizations. The list goes on…
Are there any roles you feel you’ve taken on as the 
dean that are very important or different to you?
 
 I relate to a large number of people now 
about public health much more generally
than what I’ve done in the past. People ask me 
questions about health care reform, and I will typi-
cally send them to one of my colleagues in Health 
Management and Policy who focuses on that sub-
ject. I get asked things as if I’m an expert on every-
thing.
 I certainly represent the school in many lo-
cations where we’re talking about big broad health 
issues, so a lot of my canned speeches will have 
references to the health reform debate for example, 
but I’m always personally leary of trying to over-
represent my expertise.
What does someone usually do with a master in pub-
lic health degree?
 
 Public health is a huge field – if you simply 
look at the names of our five departments: Health 
Behavior and Health Education, Health Manage-
ment and Policy, Biostatistics, Epidemiology, and 
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jobs after having spent eight years at all-male Ivy 
League schools, I decided I wanted to be at a really 
good, public co-educational research university. 
There were only three places I wanted to be: Berke-
ley, Michigan, or Wisconsin, which in those days 
were the top three. It turns out that there was a job 
available here at Michigan. Economics is a far more 
applied field than something such as literature; a 
lot of other fields exist because they’re intellectu-
ally and aesthetically important. Even with a field 
like economics that focuses on applied work, you’re 
still playing a pretty theoretical game – it’s basically 
a very mathematical game, you have to come up 
with the more sophisticated math models to “beat 
the other guy.” That’s what I was used to in gradu-
ate school, but when I got here I discovered people 
working on real world problems and it was kind 
of nifty. Here at the School of Public Health, what 
most people are doing is relevant to the real world. 
When I first got involved in tobacco policy research, 
I got some astonishing real world feedback, and I 
Environmental Health Sciences, they themselves 
are sufficiently different to suggest the breadth of 
positions and jobs available. We have over 13,000 
alums of the school, and they are all over the world 
doing all kinds of different things. The department 
I know best is Health Management and Policy. The 
single most common job that the graduates of this 
department are engaged in is management posi-
tions in health care systems. They typically start 
out at low to intermediate levels – they may be 
specifically working in hospitals, they may be work-
ing in the central office of large healthcare systems, 
frequently they’re working in a department within 
a hospital such as ambulatory care or physical 
medicine and rehabilitation – they’re getting their 
first professional experiences in hospital admin-
istration. We have a large number of people who 
work for consulting firms – they’re hired to deal 
with specific problems. A very large number of our 
graduates start out with a fellowship for one or two 
years. We have people who go work in Congress 
as aides to legislative committees; we have people 
who go work at the Centers for Disease Control and 
Prevention (CDC). The corporate sector also hires a 
lot of our graduates for health policy advice – some
pharmaceutical companies in the past years have 
hired graduates of ours to evaluate new policies 
coming from Washington D.C. A quarter of our 
students are PhD students who go on to become re-
searchers. The epidemiologists and biostatisticians
do just as the name suggests, as do the health edu-
cators.
 Coming from a background in economics, 
what attracted you to the field of public health, and 
what drew you into tobacco research?
 I was in college when my sister developed 
a rare cancer, which she died from four years later 
at the age of 21. When I got into graduate school, 
I just felt kind of impotent about dealing with the 
situation. I was in economics, and I wanted to do 
something in health economics that was specifi-
cally related to cancer. So I did a dissertation that 
was related to the use of novel chemotherapies and 
how that was a quasimarket process, as opposed to 
the usual market process. When I was looking for 
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 I got here in 1972 and I was very fortunate 
in 1975/76 to get something similar to a post-doc-
toral fellowship. It gave me the opportunity to go 
out to the National Bureau of Economic Research
at Stanford University to work with Victor Fuchs, 
who is sort of the father of health economics. I 
spent a year out there continuing some of the work 
I had been doing on medical technology, and look-
ing at changes in utilization of surgical procedures 
before and after the introduction of Medicare and 
Medicaid in 1965. We wanted to see how much 
more surgery we were seeing of various types after 
there was money available for it.
 While I was there (having just quit smok-
ing myself after having smoked about 10 years), 
I picked up a San Francisco Chronicle, and there 
was an article that stated “Anti-smokers have been 
wasting their breath.” The article argued the anti-
smoking campaign had been useless because adult 
per capita cigarette consumption was not any lower 
in 1974 than it had been in 1964, the start of the 
antismoking campaign. About a month later there 
was another article in the Chronicle, this time say-
ing that a new government survey showed continu-
ing declines in the percentage of adult American 
smokers. That struck me as inconsistent. I was just 
starting to get curious as to how to reconcile these
when I happened to hear a seminar about automo-
tive safety, during which I had one of those very
rare epiphany moments. I thought “Aha! I know 
how to address the question now”.
 The comparison between where you were 
in ’64 and where you were in ’74 was the wrong 
was getting involved in things up the level of the 
Secretary of Health and Human Services. I was 
very young, just getting into this, and it was all very 
heady. That all derived from my research. Educa-
tionally, I appreciate that the public health students 
are a good group of people who want to make a dif-
ference in the world; they’re not there to figure out 
a way to make a lot of money.
 “It’s got the technology of cigarette development, the sociology of smoking, the economics, 
politics, the biology… you name it, they’re all there, they’re all put together, and it’s just endlessly 
fascinating, and I haven’t gotten bored with it after 30 years.
Why did you feel it was important to establish the 
undergraduate class on public health?
 
 First of all, public health is a field that most 
people do not understand or can easily define. It’s 
not something like law or medicine – no one comes 
to college thinking ‘I’m going to go into public 
health’. I thought the class could function simply as 
a device for exposing some undergraduates to the 
field. I thought and hoped it would be successful in 
helping to recruit students into the profession and 
some of them into our School of Public Health. I’ve 
been saying we ought to do this for a good twenty 
years. I finally decided it was time to put our col-
lective money where my mouth has always been 
and do the class. It’s been really fun, and it’s a great 
group of people. We were worried we wouldn’t get 
more than thirty people; we figured undergradu-
ates don’t look for public health courses, since all 
previous public health courses have been for grad-
uate and professional students. All of sudden we 
started getting flooded with requests, and we filled 
up quickly. We ordered 140 textbooks and said that 
was a good place to stop. Next year if this goes well, 
and there’s enough demand, we’ll probably open 
The course up to more students.
How could an undergraduate become involved in 
public health research?
 We have several faculty members here who 
have UROP students working with them, and that 
is probably the best way to do it. There are also 
some work study research possibilities, though we 
typically want to give our own students priority for 
those. But also, if people are interested in particu-
lar areas they should come and talk to our faculty 
members over here.
Focusing on the specifics of your research career, can 
you tell us about your research with tobacco policy?
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World Health Organization can come up with goals 
for target smoking levels around the world over 
the next 10, 15, 20 years. We got selected for this 
because many years ago we did some forecasting 
where we figured out what the rate of smoking 
would be if nothing changed from the initiation and 
cessation rates going on at the time, and the an-
swer was that prevalence would drop gradually as 
more people quit than started, but then eventually 
prevalence would level off. We did this years ago, 
shortly after the Public Health Service had come 
comparison. The right question to ask was, where 
would you have been in the 70s rather than where 
you are now. So I went back and looked at smoking 
patterns before ’64 and basically did a time-series 
regression analysis projecting out where smoking 
would have been in 1974, including as factors some 
of the major anti-smoking events. It turned out that 
by that time, smoking would have been about 25% 
higher than it was had it not been for the antismok-
ing campaign.
 I published that in ’77 and instantly got all 
kinds of reactions. Before I had gotten good reac-
tions to my papers, but entirely from other academ-
ics. Here all of a sudden I received letters from the 
executive VP of the Tobacco Institute, congratulat-
ing me on discovering with publicly available data 
what they had known with their proprietary data 
for years. And then I get a phone call from the Sec-
retary of Health and Human Services asking me to 
interview to direct the very first Office on Smoking 
and Health. I’m 30 years old or so, and all of a sud-
den all these wild things are happening. That made 
smoking seem a little more interesting than medi-
cal technology to me.
 I thought when I started looking at medical 
technology that it was pretty hot stuff back then, 
but I got real bored with what I was doing with it. 
Then I thought, well here’s this little piece of veg-
etable matter rolled up in a piece of paper with 
a little filter tip on the end of it, and it has really 
been endlessly fascinating. It’s got the technology 
of cigarette development, the sociology of smok-
ing, the economics, politics, the biology…you name 
it, they’re all there, they’re all put together, and 
it’s just endlessly fascinating, and I haven’t gotten 
bored with it after 30 years.
What has your current research been, and have there 
been any major changes in the direction
of your research?
 Since becoming the Dean I haven’t had a 
whole lot of time for research unfortunately, but I 
am still continuing to do some of it. I have one col-
league, who I’m working very closely with, David 
Mendez, on a project funded by the Bloomberg 
Project. We have to provide projections so that the 
out with its Healthy People Objectives for the Na-
tion which it does every 10 years. The objective for 
the nation they had in 2010, which they had set in 
the late ‘90s, was to get smoking prevalence down 
to 12% (from about 30% in those days). Using our 
model, we determined the only way that was going 
to happen is if we practically quadrupled the rate of 
quitting and got initiation down by ¾ or something, 
so we said this was never going to happen.
 Of course we were the bad guys, but our 
argument was, the 12% target was not only unreal-
istic for 2010, it’s unrealistic for 2020! And they’ve 
got themselves between a rock and hard place now
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would say we ought to have some kind of system 
that guarantees that every American is covered by 
some form of health insurance at a bare minimum. 
Keep in mind that the health reform we’re looking 
at now is not going to do that – it’s going to leave a 
large number of people without insurance. The sec-
ond thing is that a vast majority of people in public 
health would argue that we should have a single 
payer system. We’re spending a large percentage of 
our health care expenditures on the administration
of the whole system. My wife runs Children’s and 
Women’s Hospitals here, and they have literally
hundreds of different insurance plans they have to 
deal with. Think about trying to figure that out. I 
don’t know how many people they have working on 
just getting paid, but there’s a huge waste there. So 
what is the role of public health in health reform? 
President Obama has given more attention to the 
role of public health in health reform than any of 
his predecessors. There’s a lot of discussion now 
on getting people to behave in ways that will make 
themselves healthier rather than having to rely on 
a healthcare system after they are already sick or 
injured. One of the bills includes a ten billion dollar 
public health fund. The level of interest in public 
health that this administration has been showing 
hasn’t been seen for years.
figuring out their goal for 2020, because the realis-
tic one that’s still a challenge would be no lower
than 14%, but to say that would be 2 points higher
than the goal they made for the previous decade.
Anyway as a result of the attention from that work,
the Bloomberg folks asked us to do something of
that nature at the global level, and it’s much much
tougher. The data for smoking rates in developing
countries are very very poor, so we have to be
creative in how we’re going about it. 
 Another issue I’ve been working for almost 
15 years is tobacco harm reduction, like the e-cig-
arette, one of dozens of novel products. The whole 
question is, what do you do with these things? 
Do you regulate them? How do you study them to 
figure out whether they’re really better for health 
or not? It’s far more complicated than just evaluat-
ing the individual product and how it is used by the 
individual. You then have to ask yourself, how is it 
going to affect the public as a whole? Will it get kids 
to start using tobacco who will then become smok-
ers who might not have? Will it get people who 
have quit smoking to go back to regular cigarettes? 
It’s a very complicated set of issues but that’s what 
I have been focusing most of my time on in the last 
15 years or so, and it’s the toughest problem in 
tobacco policy that I’ve run up against.
The issue of healthcare reform has been on the minds 
of Americans lately. How does public health play into 
healthcare reform?
 First of all, nearly everyone in public health 
